Overall, TAVI has become a viable option for selected high-risk patients with severe symptomatic pure native AR and has now been incorporated into contemporary guidelines in this setting.
Joao Matteo Rampone, Samuele Sandrone, S. Capoccia et al.· Reviews in cardiovascular me...· 0 citations
A non-invasive surrogate of RV-PA uncoupling, TAPSE/PASP, was associated with increased mortality irrespective of treatment modality and a potential survival benefit of TTVI was observed in patients within the intermediate RV-PA coupling tercile, but not in the lowest or highest terciles.
R. Hahn, J. Dreyfus, N. Ajmone Marsan et al.· European Heart Journal· 0 citations
An integrated, stepwise management algorithm is proposed that incorporates early risk markers, including natriuretic peptides, to guide the timing of intervention before irreversible myocardial damage occurs and enables more precise patient phenotyping and treatment tailoring.
C. Gaspardone, Paolo Costa, G. Barone et al.· Reviews in cardiovascular me...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.